drugset / Trial / NCT07128628
A Study Evaluating the Safety and Efficacy of a Fixed-Dose Combination for Dry Eye Disease
RandomizedParallel-groupDouble-blindTreatment
Summary
A 4-Week, Randomized, Double-Masked, Parallel-Group, Active-Controlled, Multicenter Study Evaluating Lifitegrast/Perfluorohexyloctane Fixed-Dose Combination Administered Twice Daily on Signs and Symptoms of Dry Eye Disease
Timeline
- Start
- 2025-10-24
- Primary completion
- 2026-05-28
- Completion
- 2026-05-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Lifitegrast | Unknown | — | Topical |
| Comparator | Perfluorohexyloctane | Unknown | — | Topical |